Net Loss Per Share (as restated) (Tables)

9 Months Ended

Sep. 30, 2024

Reconciliation of Basic and Diluted Net Loss Per Share

The following table sets forth the computation of basic and diluted net loss per share of Common Stock, Series A Preferred Stock, and Series B Preferred Stock (in thousands, except share and per share amounts):


	Three Months Ended September 30,
	2024						2023
	Series A Preferred Stock		Series B Preferred Stock		Common Stock		Series A Preferred Stock		Series B Preferred Stock		Common Stock
Net loss per share, basic and diluted:
Numerator
Allocation of losses	$	(14,610)	$	(704)	$	(53,714)	$	(36,427)	$	—	$	(3,680)
Denominator
Weighted-average shares outstanding	346,045		16,667		50,889,433		1,062,542		—		4,015,661
Weighted-average pre-funded warrants outstanding	—		—		—		—		—		278,151
Number of shares used in per share computation	346,045		16,667		50,889,433		1,062,542		—		4,293,812
Net loss per share, basic and diluted	$	(42.22)	$	(42.24)	$	(1.06)	$	(34.28)	$	—	$	(0.86)

	Nine Months Ended September 30,
	2024						2023
	Series A Preferred Stock		Series B Preferred Stock		Common Stock		Series A Preferred Stock		Series B Preferred Stock		Common Stock
Net loss per share, basic and diluted:
Numerator
Allocation of losses	$	(36,733)	$	(9,105)	$	(105,884)	$	(217,573)	$	—	$	(58,037)
Denominator
Weighted-average shares outstanding	383,903		95,158		44,146,958		371,286		—		3,116,434
Weighted-average pre-funded warrants outstanding	—		—		116,788		—		—		845,112
Number of shares used in per share computation	383,903		95,158		44,263,746		371,286		—		3,961,546
Net loss per share, basic and diluted	$	(95.68)	$	(95.68)	$	(2.39)	$	(586.00)	$	—	$	(14.65)

Weighted-Average Equity Instruments Excluded from Calculation of Diluted Net Loss Per Share

The following weighted-average equity instruments were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the periods presented:


	Three Months Ended September 30,		Nine Months Ended September 30,
	2024	2023	2024	2023
Options to purchase common stock	4,733,609	3,135,672	4,583,260	1,426,224
Unvested restricted stock units	65,925	—	69,503	252
Outstanding Parapyre warrants	684,407	—	684,407	—